GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (CHIX:VITRs) » Definitions » Median PS Value

Vitrolife AB (CHIX:VITRS) Median PS Value : kr321.94 (As of Jun. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vitrolife AB Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Vitrolife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr25.842. Vitrolife AB's 10-Year median PS Ratio is 12.458. Therefore, the Median PS Value for today is kr321.94.

As of today (2024-06-23), Vitrolife AB's share price is kr169.00. Vitrolife AB's Median PS Value is kr321.94. Therefore, Vitrolife AB's Price to Median PS Value for today is 0.52.

The historical rank and industry rank for Vitrolife AB's Median PS Value or its related term are showing as below:

CHIX:VITRs' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.45   Med: 2.04   Max: 3.76
Current: 0.52

During the past 13 years, the highest Price to Median PS Value of Vitrolife AB was 3.76. The lowest was 0.45. And the median was 2.04.

CHIX:VITRs's Price-to-Median-PS-Value is ranked better than
73.27% of 318 companies
in the Medical Devices & Instruments industry
Industry Median: 0.8 vs CHIX:VITRs: 0.52

Vitrolife AB Median PS Value Historical Data

The historical data trend for Vitrolife AB's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Median PS Value Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.31 106.16 176.42 313.58 290.27

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 291.69 321.49 447.62 290.27 280.14

Competitive Comparison of Vitrolife AB's Median PS Value

For the Medical Devices subindustry, Vitrolife AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Price-to-Median-PS-Value falls into.



Vitrolife AB Median PS Value Calculation

Vitrolife AB's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=25.842*12.458
=321.94

10-Year Median PS Ratio is 12.458.
Vitrolife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr25.842.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB  (CHIX:VITRs) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Vitrolife AB's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=169.00/321.94
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitrolife AB Median PS Value Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (CHIX:VITRS) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (CHIX:VITRS) Headlines

No Headlines